Susan M Keenan

Title: The Innovative Contributions of Susan M. Keenan

Introduction

Susan M. Keenan is a notable inventor based in Longmont, Colorado. She has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that address critical health issues. With a total of 3 patents, her work has the potential to impact the treatment of various medical conditions.

Latest Patents

Keenan's latest patents include innovative compounds aimed at treating hyperproliferative disorders. One of her key inventions is related to anti-mitotic anti-proliferative compounds, specifically substituted triazole compounds. These compounds are designed to be used in pharmaceutical compositions for treating pathologies linked to hyperproliferative disorders. Another significant patent involves opioid receptor subtype-selective agents, which are compounds and pharmaceutical compositions that target conditions mediated by opioid receptors. These inventions highlight her commitment to advancing medical treatments through innovative research.

Career Highlights

Throughout her career, Susan M. Keenan has worked with esteemed institutions such as the University of Medicine and Dentistry of New Jersey and Rutgers, The State University of New Jersey. Her experience in these organizations has allowed her to collaborate with other professionals and contribute to groundbreaking research in her field.

Collaborations

Keenan has collaborated with notable colleagues, including William J. Welsh and Qiang Zhang. These partnerships have further enriched her research and development efforts, leading to the successful creation of her patented compounds.

Conclusion

Susan M. Keenan's innovative work in pharmaceuticals demonstrates her dedication to improving healthcare through her inventions. Her patents reflect a deep understanding of complex medical issues and a commitment to finding effective solutions.